Navigation Links
NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share
Date:7/10/2014

the documents Aware files from time to time with the Securities and Exchange Commission, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2013 and other reports and filings made with the Securities and Exchange Commission.

Aware is a trademark or registered trademark of Aware, Inc.
Any other trademarks appearing herein are the property of their respective owners.


'/>"/>
SOURCE Aware, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. NASDAQ Sets Ex-Dividend Date for Aware, Inc.s Special Cash Dividend of $1.80 Per Share
2. Dynasil Regains Compliance with NASDAQ Listing Requirements
3. Aware, Inc. Reports First Quarter 2012 Financial Results
4. Aware, Inc. Reports Second Quarter 2012 Financial Results
5. Aware, Inc. Reports Third Quarter 2012 Financial Results
6. Aware, Inc. Declares Special Cash Dividend of $1.80 Per Share, or Approximately $40 Million in Total
7. Aware, Inc. Reports First Quarter 2013 Financial Results
8. Aware, Inc. Reports Second Quarter 2013 Financial Results
9. Aware, Inc. Reports Third Quarter 2013 Financial Results
10. Patient in vegetative state not just aware, but paying attention
11. Dinosaur fossil: Even specialized predators didnt turn down free meals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/2/2015)... -- Fingerprint Cards (FPC) has received an ... distributor World Peace Industrial Group (WPI), part of WPG ... major part of the shipments will take place during ... manufacturers in China . The order ... revenue guidance of + 1 000 MSEK for 2015.  ...
(Date:3/31/2015)... , March 31, 2015   Guidepoint , a ... of the Post-Surgical Pain Management TRACKER, part of the ... usage trends in the medical device and therapeutics markets. ... data including treatment volumes, market share, and adoption rates ... associated with joint surgery. The Post-Surgical Pain ...
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and Markets ... "Face and Voice Biometrics - Global Strategic Business Report" report ... for Face and Voice Biometrics in US$ Thousands by the following ... analytics for the US, Canada , ... , Middle East & ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
... by Johns Hopkins scientists has,found the first clear ... remarkable ability to recognize and respond to a ... of genes whose,only apparent function is to jump ... themselves out of the genetic material, and scientists,have ...
... Fast-track recruitment has begun for a trial to investigate ... the National Institute of Allergy and Infectious Diseases (NIAID), ... today. , Sites in Rochester, NY, Baltimore and Los ... The clinical sites are part of the NIAID-sponsored Vaccine ...
... Roger Brent, President and Director of Research at ... announced today ,the release of a new approach ... 2005 edition of Nature,Biotechnology.,The research article, entitled ... 1.0" (pdf) ,describes MSI's discrete stochastic event simulator, ...
Cached Biology News:Gene sequencing explains bioremediation 'bug' 2Gene sequencing explains bioremediation 'bug' 3NIAID Initiates Trial of Experimental Avian Flu Vaccine 2MSI releases 'moleculizer' - a new approach to simulation of intracellular biochemical networks 2MSI releases 'moleculizer' - a new approach to simulation of intracellular biochemical networks 3
(Date:5/4/2015)... , May 4, 2015 GliaCure, ... of novel therapies for neurological and neuropsychiatric disorders ... initiated dosing of Alzheimer,s patients in a Phase ... GC021109, a compound developed as a potential disease-modifying ... is innovative in that it both promotes the ...
(Date:5/4/2015)... TORONTO , May 4, 2015 /PRNewswire/ - ... pleased to announce the appointment of Dr. Roger ... extensive experience guiding biotech companies in matters including ... Fluorinov,s leadership team and adds significant regulatory expertise ... Dr. Garceau brings 30 years of pharmaceutical ...
(Date:5/4/2015)... Genedata, a leading provider of advanced ... research, today announced the release of Genedata ... enterprise solution for biologics R&D. This first-in-class workflow ... and development of novel biotherapeutics. Version 5.0 enables ... optimization and developability requirements. Genedata will present highlights ...
(Date:5/4/2015)... -- China Cord Blood Corporation (NYSE: CO ) ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced that the Company has been informed that Golden ... Kong listed company and a substantial shareholder ... "Agreement") to purchase the Company,s outstanding 7% senior convertible ...
Breaking Biology Technology:GliaCure Initiates Phase 1b Dosing in Alzheimer's Patients 2Roger J Garceau joins Fluorinov board, adds clinical expertise to bromodomain program and oncology pipeline 2Roger J Garceau joins Fluorinov board, adds clinical expertise to bromodomain program and oncology pipeline 3Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 2Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 3Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 4China Cord Blood Corporation Receives Notice of a Transaction Regarding its 7% Senior Convertible Notes Due 2017 Held by KKR 2China Cord Blood Corporation Receives Notice of a Transaction Regarding its 7% Senior Convertible Notes Due 2017 Held by KKR 3
... 18 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ... Society of Clinical Oncology (ASCO) Annual Meeting being held ... to our product candidates Stimuvax(R), PX-866 and PX-12 are ... Web site, www.abstract.asco.org ., Abstracts ...
... MEDIA ALERTWASHINGTON, May 18 Focusing on ... essential to reducing preventable adverse events, and ... change, influential leaders will gather at the ... to discuss the fundamental shifts necessary to ...
... Paragon Bioservices, Inc., a contract research and manufacturing organization ... Supplier Award for exceptional performance in support of Lilly,s ... in this manner by such an elite organization and ... of quality, excellence and superior customer service in the ...
Cached Biology Technology:Oncothyreon announces presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 2Oncothyreon announces presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 3Healthcare Leaders to Address Patient Safety and Reform at the National Patient Safety Foundation Congress, Washington, DC, May 20-22 2Healthcare Leaders to Address Patient Safety and Reform at the National Patient Safety Foundation Congress, Washington, DC, May 20-22 3
Amino Acid Analysis is performed using ion-exchange separation of the amino acids from acid hydrolysates, followed by ninhydrin detection. Typical quantities required are 0.1 to 0.5 mg, depending on...
...
ANTI CORTIS BIN GLOB...
MOUSE ANTI BOVINE WC1:FITC Immunogen: Bovine lymphocytes...
Biology Products: